SECURE CLOUD ACCESS

ANS-1 SYSTEM

ANS-1 system integrates 3 technologies based on Galvanic skin response ,  photoplethysmography analysis and oscillometry to assess the Autonomic Nervous System and Peripheral circulation.

ANS-1, medical device, early detection of diabetes complications

 ​AUTONOMIC NERVOUS SYSTEM ASSESSMENT

TECHNOLOGIES :
GALVANIC SKIN RESPONSE+ OSCILLOMETRY + PHOTOPLETHYSMOGRAPHY

      
ANS-1 System manages the Autonomic Nervous System battery of tests recommended by the American Academy of Neurology since 1996, and the Cardiovascular Autonomic Neuropathy Subcommittee of the Toronto Consensus Panel on Diabetic Neuropathy, for assessing the Autonomic Nervous System.

Autonomic testing is recommended for all patients with type 2 diabetes at the time of the diagnosis, and 5 years after diagnosis in individuals with type 1 diabetes.
( Boulton et al., 2005;Tesfaye et al., 2010;Spallone et al., 2011; Bernardi et al.,2011.)

Patient setup ANS-1, instruction for use
ANS-1 BENEFITS
Benefit of ANS-1, no human error
Benefit of ANS-1, clear report
Benefit of ANS-1, accurate result
Benefit of ANS-1, simultaneous measurement, 7-10 minutes
Benefit of ANS-1, ANS and Artery overview
ANS-1 MARKERS

Vascular function Assessment 
Peripheral circulation  from
Photoplethysmography (PTG) analysis​​
​Brachial blood pressure

ANS-1 REVIEW BY DR. JIMMY NINH
ANS-1 FEATURES
cardiac autonomic neuropathy
microcirculation disorders
sudomotor dysfunction
ANS Assessment :
Sudomotor markers 
​Heart rate variability Analysis and Cardiac Autonomic Reflex Tests(  Valsalva Ratio, E/I Ratio, K30/15 Ratio and Systolic response difference while standing).​​